Novartis AG ADR (NVSN)

Mexico
Currency in MXN
Disclaimer
1,678.00
0.00
(0.00%)
Closed
Day's Range
1,678.00
1,678.00
52 wk Range
1,520.00
1,871.21
Volume
0
Prev. Close
1,720.31
Open
1,678
Day's Range
1,678-1,678
52 wk Range
1,520-1,871.21
Volume
0
Average Volume (3m)
381
1-Year Change
4.31%
Shares Outstanding
2,068,263,550
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
116.00
Upside +14.38%

People Also Watch

91.79
NVO
+0.72%
550.01
LLY
-0.41%
310.61
ACN
-2.01%
153.91
ABBV
-0.48%
159.02
JNJ
-0.77%
How do you feel today about NVSN?
Vote to see community's results!
or

Novartis AG ADR Company Profile

Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Employees
103000

Income Statement